Tomas Bos

855 total citations
16 papers, 659 citations indexed

About

Tomas Bos is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Tomas Bos has authored 16 papers receiving a total of 659 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 4 papers in Hematology and 4 papers in Genetics. Recurrent topics in Tomas Bos's work include Multiple Myeloma Research and Treatments (4 papers), Protein Degradation and Inhibitors (4 papers) and Virus-based gene therapy research (3 papers). Tomas Bos is often cited by papers focused on Multiple Myeloma Research and Treatments (4 papers), Protein Degradation and Inhibitors (4 papers) and Virus-based gene therapy research (3 papers). Tomas Bos collaborates with scholars based in Belgium, United States and Singapore. Tomas Bos's co-authors include Carlo Heirman, Kris Thielemans, Karin Vanderkerken, Elke De Bruyne, Tony Lahoutte, Karel Fostier, Aude Bonehill, Bart Neyns, Sandra Tuyaerts and An M. T. Van Nuffel and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Blood.

In The Last Decade

Tomas Bos

15 papers receiving 649 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tomas Bos Belgium	13	424	187	174	107	86	16	659
Amanda P. Liggins United Kingdom	10	1.4k 3.3×	217 1.2×	125 0.7×	55 0.5×	55 0.6×	13	1.7k
Patricia Vusio France	12	434 1.0×	413 2.2×	337 1.9×	70 0.7×	52 0.6×	16	903
Seyed Mohammad Ali Hosseini Rad Iran	15	436 1.0×	118 0.6×	265 1.5×	100 0.9×	27 0.3×	29	715
Gretchen A. Baltus United States	10	664 1.6×	227 1.2×	117 0.7×	73 0.7×	32 0.4×	13	925
H. Carlo Maurer United States	17	493 1.2×	201 1.1×	370 2.1×	157 1.5×	78 0.9×	33	931
Shiwei Zheng United States	9	862 2.0×	431 2.3×	186 1.1×	87 0.8×	29 0.3×	11	1.2k
Lucio Gómez Spain	10	286 0.7×	323 1.7×	237 1.4×	62 0.6×	39 0.5×	14	667
Jeongheon Yoon United States	14	274 0.6×	426 2.3×	274 1.6×	124 1.2×	32 0.4×	19	776
S. Hardy United States	3	473 1.1×	100 0.5×	137 0.8×	287 2.7×	68 0.8×	6	729
Ronit Pasvolsky Israel	11	284 0.7×	362 1.9×	200 1.1×	70 0.7×	30 0.3×	19	769

Countries citing papers authored by Tomas Bos

Since Specialization

Citations

This map shows the geographic impact of Tomas Bos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomas Bos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomas Bos more than expected).

Fields of papers citing papers by Tomas Bos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomas Bos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomas Bos. The network helps show where Tomas Bos may publish in the future.

Co-authorship network of co-authors of Tomas Bos

This figure shows the co-authorship network connecting the top 25 collaborators of Tomas Bos. A scholar is included among the top collaborators of Tomas Bos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomas Bos. Tomas Bos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Bos, Tomas, et al.. (2017). The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells. Nature Communications. 8(1). 1034–1034. 50 indexed citations

Batra, Ranjan, Thomas Stark, Alex E. Clark, et al.. (2016). RNA-binding protein CPEB1 remodels host and viral RNA landscapes. Nature Structural & Molecular Biology. 23(12). 1101–1110. 42 indexed citations

Bos, Tomas, Julia K. Nussbacher, Stefan Aigner, & G Yeo. (2016). Tethered Function Assays as Tools to Elucidate the Molecular Roles of RNA-Binding Proteins. Advances in experimental medicine and biology. 907. 61–88. 29 indexed citations

Goethals, Lode, Tomas Bos, Luc Baeyens, et al.. (2014). Camelid reporter gene imaging: a generic method for in vivo cell tracking. EJNMMI Research. 4(1). 32–32. 4 indexed citations

Emeagi, Perpetua U., Sandra Van Lint, Cleo Goyvaerts, et al.. (2012). Proinflammatory Characteristics of SMAC/DIABLO-Induced Cell Death in Antitumor Therapy. Cancer Research. 72(6). 1342–1352. 26 indexed citations

Keyaerts, Marleen, Vicky Caveliers, Karine Breckpot, et al.. (2012). Inhibition of Firefly Luciferase by General Anesthetics: Effect on In Vitro and In Vivo Bioluminescence Imaging. PLoS ONE. 7(1). e30061–e30061. 35 indexed citations

Dmitriev, Petr, Eugénie Ansseau, Tomas Bos, et al.. (2011). The Krüppel-like Factor 15 as a Molecular Link between Myogenic Factors and a Chromosome 4q Transcriptional Enhancer Implicated in Facioscapulohumeral Dystrophy. Journal of Biological Chemistry. 286(52). 44620–44631. 21 indexed citations

Bos, Tomas, Elke De Bruyne, Sandra Van Lint, Carlo Heirman, & Karin Vanderkerken. (2010). Large double copy vectors are functional but show a size-dependent decline in transduction efficiency. Journal of Biotechnology. 150(1). 37–40. 24 indexed citations

Bruyne, Elke De, Tomas Bos, Frans Schuit, et al.. (2010). IGF-1 suppresses Bim expression in multiple myeloma via epigenetic and posttranslational mechanisms. Blood. 115(12). 2430–2440. 84 indexed citations

10.

Baeyens, Luc, Stefan Bonné, Tomas Bos, et al.. (2009). Notch Signaling as Gatekeeper of Rat Acinar-to-β-Cell Conversion in Vitro. Gastroenterology. 136(5). 1750–1760.e13. 64 indexed citations

11.

Bos, Tomas, Elke De Bruyne, Carlo Heirman, & Karin Vanderkerken. (2009). In Search of the Most Suitable Lentiviral shRNA System. Current Gene Therapy. 9(3). 192–211. 15 indexed citations

12.

Vanderkerken, Karin, Elke De Bruyne, Sarah Deleu, et al.. (2009). Epigenetic Regulation of Multiple Myeloma Within its Bone Marrow Microenvironment. Clinical Lymphoma & Myeloma. 9. S29–S30.

13.

Keyaerts, Marleen, Jacob Verschueren, Tomas Bos, et al.. (2008). Dynamic bioluminescence imaging for quantitative tumour burden assessment using IV or IP administration of d-luciferin: effect on intensity, time kinetics and repeatability of photon emission. European Journal of Nuclear Medicine and Molecular Imaging. 35(5). 999–1007. 74 indexed citations

14.

Bonehill, Aude, Sandra Tuyaerts, An M. T. Van Nuffel, et al.. (2008). Enhancing the T-cell Stimulatory Capacity of Human Dendritic Cells by Co-electroporation With CD40L, CD70 and Constitutively Active TLR4 Encoding mRNA. Molecular Therapy. 16(6). 1170–1180. 151 indexed citations

15.

Bruyne, Elke De, Tomas Bos, Kewal Asosingh, et al.. (2008). Epigenetic Silencing of the Tetraspanin CD9 during Disease Progression in Multiple Myeloma Cells and Correlation with Survival. Clinical Cancer Research. 14(10). 2918–2926. 38 indexed citations

16.

Bruyne, Elke De, Tomas Bos, Sarah Deleu, et al.. (2007). Regulation of Bim Expression by IGF-1 in the 5T33MM Murine Model for Multiple Myeloma.. Blood. 110(11). 3512–3512. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact